387 related articles for article (PubMed ID: 24447269)
1. Effects of calcineurin inhibitors on paraoxonase and arylesterase activity after a kidney transplant.
Kahvecioglu S; Ersoy A; Gullulu M; Dirican M
Exp Clin Transplant; 2014 Aug; 12(4):334-42. PubMed ID: 24447269
[TBL] [Abstract][Full Text] [Related]
2. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T
Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
[TBL] [Abstract][Full Text] [Related]
3. Assessing the metabolic effects of calcineurin inhibitors in renal transplant recipients by urine metabolic profiling.
Diémé B; Halimi JM; Emond P; Büchler M; Nadal-Desbarat L; Blasco H; Le Guellec C
Transplantation; 2014 Jul; 98(2):195-201. PubMed ID: 24598938
[TBL] [Abstract][Full Text] [Related]
4. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
[TBL] [Abstract][Full Text] [Related]
5. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.
Jardine AG
Transpl Int; 2005 Apr; 18(4):379-84. PubMed ID: 15773954
[TBL] [Abstract][Full Text] [Related]
6. Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters.
Seymen P; Yildiz M; Türkmen MF; Titiz MI; Seymen HO
Transplant Proc; 2009 Dec; 41(10):4181-3. PubMed ID: 20005364
[TBL] [Abstract][Full Text] [Related]
7. Insulin requirement after a renal transplant in patients with type 2 diabetes: the choice of calcineurin inhibitors.
van den Hoogen MW; van der Hoeven AM; Hilbrands LB
Exp Clin Transplant; 2013 Jun; 11(3):234-8. PubMed ID: 23432070
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
Batista F; Auyanet I; Torregrosa JV; Oppenheimer F
Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy After Renal Transplant: Single Center Experience From the Middle East in Patients Using Different Calcineurin Inhibitors.
Al-Otaibi T; Gheith OA; Nagib AM; Nair P; Zakaria ZE; Halim MA; Said T; Abdelmonem M; Makkeyah Y; Aboatteya H; Elsawi IS; Atta AF
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):99-104. PubMed ID: 30777531
[TBL] [Abstract][Full Text] [Related]
10. A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors.
Prasad GV; Nash MM; McFarlane PA; Zaltzman JS
Nephron Clin Pract; 2004; 97(2):c35-40. PubMed ID: 15218328
[TBL] [Abstract][Full Text] [Related]
11. Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
Gathogo E; Harber M; Bhagani S; Levy J; Jones R; Hilton R; Davies G; Post FA;
Transplantation; 2016 Apr; 100(4):871-8. PubMed ID: 26413990
[TBL] [Abstract][Full Text] [Related]
12. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year.
Rowshani AT; Scholten EM; Bemelman F; Eikmans M; Idu M; Roos-van Groningen MC; Surachno JS; Mallat MJ; Paul LC; de Fijter JW; Bajema IM; ten Berge I; Florquin S
J Am Soc Nephrol; 2006 Jan; 17(1):305-12. PubMed ID: 16306168
[TBL] [Abstract][Full Text] [Related]
13. Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients.
Beckebaum S; Klein C; Varghese J; Sotiropoulos GC; Saner F; Schmitz K; Gerken G; Paul A; Cicinnati VR
Aliment Pharmacol Ther; 2009 Oct; 30(8):834-42. PubMed ID: 19624550
[TBL] [Abstract][Full Text] [Related]
14. Changes in oxidative stress in renal graft patients receiving calcineurin inhibitors: cyclosporine versus tacrolimus.
Akbasli AC; Keven K; Erbay B; Nebioglu S
Exp Clin Transplant; 2012 Oct; 10(5):439-45. PubMed ID: 22817282
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
Sarandol A; Sarandol E; Eker SS; Karaagac EU; Hizli BZ; Dirican M; Kirli S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1103-8. PubMed ID: 16716479
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients.
Baid-Agrawal S; Delmonico FL; Tolkoff-Rubin NE; Farrell M; Williams WW; Shih V; Auchincloss H; Cosimi AB; Pascual M
Transplantation; 2004 Apr; 77(8):1199-202. PubMed ID: 15114085
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine versus tacrolimus maintenance therapy in renal transplant.
Alghamdi S; Nabi Z; Skolnik E; Alkorbi L; Albaqumi M
Exp Clin Transplant; 2011 Jun; 9(3):170-4. PubMed ID: 21649564
[TBL] [Abstract][Full Text] [Related]
19. Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus.
Artz MA; Boots JM; Ligtenberg G; Roodnat JI; Christiaans MH; Vos PF; Blom HJ; Sweep FC; Demacker PN; Hilbrands LB
J Am Soc Nephrol; 2003 Jul; 14(7):1880-8. PubMed ID: 12819249
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk estimates and risk factors in renal transplant recipients.
Krämer BK; Böger C; Krüger B; Marienhagen J; Pietrzyk M; Obed A; Paczek L; Mack M; Banas B
Transplant Proc; 2005 May; 37(4):1868-70. PubMed ID: 15919488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
